Data completeness
4/8 — Partial
METAXALONE (metaxalone) by Pfizer is rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions has not been established, but may be due to general cns depression. First approved in 2015.
Drug data last refreshed 17h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Metaxalone is an oral muscle relaxant tablet approved in 2015 for acute, painful musculoskeletal conditions used adjunctively with rest and physical therapy. Its mechanism is believed to involve general CNS depression rather than direct action on muscle fibers, motor end plates, or nerve fibers. It is a small molecule indicated for symptomatic relief of discomfort in acute musculoskeletal pain.
$0.304MPart D
Peak16.5 years to LOEDrug is at peak lifecycle with minimal commercial activity (1,871 Part D claims in 2023); brand team likely small and focused on maintenance rather than growth initiatives.
Mechanism of Action
rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions has not been established, but may be due to general CNS depression. Metaxalone has no direct action on the contractile mechanism of striated muscle, the motor end plate,…
Pharmacologic Class:
Muscle Relaxant
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Metaxalone currently has zero linked job openings, reflecting its mature, low-volume commercial profile ($304K Part D spending) and minimal market expansion. Career opportunities are limited to maintenance and lifecycle management roles rather than growth-oriented positions.
Brand Manager
Worked on METAXALONE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.